New Algorithm: Lymphadenopathy in Pediatric Patients
July 5, 2023
Specialists in our Cancer and Blood Disorders Center have created a new evidence-based algorithm to help PCPs evaluate lymphadenopathy in children and teens, manage pediatric patients effectively, and know when to refer to pediatric oncology.
View the lymphadenopathy algorithm.
Lymphadenopathy is extremely common in pediatrics with the vast majority of cases being benign or related to an infectious etiology. This algorithm will help ensure patients who are at high risk for malignancy are referred to oncology and will help provide guidance for management of patients who are likely to have a benign etiology of lymphadenopathy.
Find other algorithms and other clinical care resources for PCPs on the Seattle Children’s website at seattlechildrens.org/algorithms.